Skip to main content
NCBI home page
Heart logoLink to Heart
editorial
. 1996 Mar;75(3):215–217. doi: 10.1136/hrt.75.3.215

Vascular gene transfer.

K M Channon, M A Blazing, S E George
PMCID: PMC484273  PMID: 8800979

Full text

PDF
215

Images in this article

216Image
on p.216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang M. W., Barr E., Seltzer J., Jiang Y. Q., Nabel G. J., Nabel E. G., Parmacek M. S., Leiden J. M. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995 Jan 27;267(5197):518–522. doi: 10.1126/science.7824950. [DOI] [PubMed] [Google Scholar]
  2. Chen S. J., Wilson J. M., Muller D. W. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation. 1994 May;89(5):1922–1928. doi: 10.1161/01.cir.89.5.1922. [DOI] [PubMed] [Google Scholar]
  3. Feldman L. J., Steg P. G., Zheng L. P., Chen D., Kearney M., McGarr S. E., Barry J. J., Dedieu J. F., Perricaudet M., Isner J. M. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest. 1995 Jun;95(6):2662–2671. doi: 10.1172/JCI117968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. French B. A., Mazur W., Ali N. M., Geske R. S., Finnigan J. P., Rodgers G. P., Roberts R., Raizner A. E. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation. 1994 Nov;90(5):2402–2413. doi: 10.1161/01.cir.90.5.2402. [DOI] [PubMed] [Google Scholar]
  5. Isner J. M., Feldman L. J. Gene therapy for arterial disease. Lancet. 1994 Dec 17;344(8938):1653–1654. doi: 10.1016/s0140-6736(94)90454-5. [DOI] [PubMed] [Google Scholar]
  6. Isner J. M., Walsh K., Symes J., Pieczek A., Takeshita S., Lowry J., Rossow S., Rosenfield K., Weir L., Brogi E. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation. 1995 Jun 1;91(11):2687–2692. doi: 10.1161/01.cir.91.11.2687. [DOI] [PubMed] [Google Scholar]
  7. Mann M. J., Gibbons G. H., Kernoff R. S., Diet F. P., Tsao P. S., Cooke J. P., Kaneda Y., Dzau V. J. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4502–4506. doi: 10.1073/pnas.92.10.4502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Muller D. W. Gene therapy for cardiovascular disease. Br Heart J. 1994 Oct;72(4):309–312. doi: 10.1136/hrt.72.4.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nabel E. G., Plautz G., Nabel G. J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990 Sep 14;249(4974):1285–1288. doi: 10.1126/science.2119055. [DOI] [PubMed] [Google Scholar]
  10. Nabel E. G., Pompili V. J., Plautz G. E., Nabel G. J. Gene transfer and vascular disease. Cardiovasc Res. 1994 Apr;28(4):445–455. doi: 10.1093/cvr/28.4.445. [DOI] [PubMed] [Google Scholar]
  11. Ohno T., Gordon D., San H., Pompili V. J., Imperiale M. J., Nabel G. J., Nabel E. G. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 1994 Aug 5;265(5173):781–784. doi: 10.1126/science.8047883. [DOI] [PubMed] [Google Scholar]
  12. Riessen R., Isner J. M. Prospects for site-specific delivery of pharmacologic and molecular therapies. J Am Coll Cardiol. 1994 Apr;23(5):1234–1244. doi: 10.1016/0735-1097(94)90616-5. [DOI] [PubMed] [Google Scholar]
  13. Rome J. J., Shayani V., Flugelman M. Y., Newman K. D., Farb A., Virmani R., Dichek D. A. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 1994 Jan;14(1):148–161. doi: 10.1161/01.atv.14.1.148. [DOI] [PubMed] [Google Scholar]
  14. Schulick A. H., Newman K. D., Virmani R., Dichek D. A. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation. 1995 May 1;91(9):2407–2414. doi: 10.1161/01.cir.91.9.2407. [DOI] [PubMed] [Google Scholar]
  15. Steg P. G., Feldman L. J., Scoazec J. Y., Tahlil O., Barry J. J., Boulechfar S., Ragot T., Isner J. M., Perricaudet M. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation. 1994 Oct;90(4):1648–1656. doi: 10.1161/01.cir.90.4.1648. [DOI] [PubMed] [Google Scholar]
  16. Takeshita S., Gal D., Leclerc G., Pickering J. G., Riessen R., Weir L., Isner J. M. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest. 1994 Feb;93(2):652–661. doi: 10.1172/JCI117017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Willard J. E., Landau C., Glamann D. B., Burns D., Jessen M. E., Pirwitz M. J., Gerard R. D., Meidell R. S. Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 1994 May;89(5):2190–2197. doi: 10.1161/01.cir.89.5.2190. [DOI] [PubMed] [Google Scholar]
  18. Yang Y., Trinchieri G., Wilson J. M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med. 1995 Sep;1(9):890–893. doi: 10.1038/nm0995-890. [DOI] [PubMed] [Google Scholar]
  19. von der Leyen H. E., Gibbons G. H., Morishita R., Lewis N. P., Zhang L., Nakajima M., Kaneda Y., Cooke J. P., Dzau V. J. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1137–1141. doi: 10.1073/pnas.92.4.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES